Nicotine-Induced VEGF Levels in NSCLC Cells Are Modulated by PKA, Hyaluronan, and p53
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262211103 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Caroline Wozniak und 9 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, Eastern Michigan University, Ypsilanti, MI 48197, USA. Hauptthemen laut MEDLINE: Hyaluronic Acid, Carcinoma, Non-Small-Cell Lung, Cyclic AMP-Dependent Protein Kinases, Tumor Suppressor Protein p53. Die Arbeit nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Institute of General Medical Sciences of the National Institutes of Health.
Abstract (Originalsprache)
Nicotine promotes non-small cell lung cancer (NSCLC) survival in part by elevating vascular endothelial growth factor (VEGF), yet the upstream regulatory mechanisms remain unclear. Here we identify a PKA–HA–p53 regulatory axis that governs nicotine-driven VEGF levels and survival in A549 (p53+/+) and H1299 (p53-null) cells. Nicotine increased VEGF levels in the media, an effect augmented by protein kinase A (PKA) activation and reduced by PKA inhibition. Blocking hyaluronan (HA) synthesis with 4-methylumbelliferone (4-MU) lowered VEGF levels and diminished the nicotine response, suggesting that HA–CD44 contributes to PKA-linked survival pathways. In A549, p53 inhibition or knockdown enhanced PKA activity and VEGF levels, indicating that p53 constrains this axis; by contrast, H1299 displayed sustained nicotine responsiveness consistent with p53 loss. Pharmacologic nAChR/β-adrenergic blockade blunted nicotine-induced PKA signaling. Functionally, VEGF immunodepletion or co-treatment with a PKA inhibitor, 4-MU, or anti-VEGF antibodies reduced nicotine-supported viability and increased apoptosis, while the addition of purified VEGF rescued survival, establishing the role of VEGF in this pathway. Collectively, these findings delineate a mechanistic network in which PKA, HA–CD44 signaling, and p53 integrate nicotinic cues to control VEGF media levels and cell survival, identifying potential targets (PKA, HA synthesis, VEGF) for mitigating nicotine-mediated NSCLC progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemistry Department, Eastern Michigan University, Ypsilanti, MI 48197, USA.
ORCID-Profile: Jeffrey Guthrie, Hedeel Guy Evans
Förderung
- NIGMS NIH HHS
- NIH HHS
- National Institute of General Medical Sciences of the National Institutes of Health
Zitieren
APA
Wozniak, C., Cobos, A., Sabri, A., Goel, S., Lopo, B., Sarofim, S., Chutipassakul, C., Guthrie, J., Heyl, D., & Evans, H. G. (2025). Nicotine-Induced VEGF Levels in NSCLC Cells Are Modulated by PKA, Hyaluronan, and p53. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262211103
Vancouver
Wozniak C, Cobos A, Sabri A, Goel S, Lopo B, Sarofim S, et al. Nicotine-Induced VEGF Levels in NSCLC Cells Are Modulated by PKA, Hyaluronan, and p53. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262211103
BibTeX
@article{Wozniak2025,
author = {Wozniak, Caroline and Cobos, Alvaro and Sabri, Aya and Goel, Stuti and Lopo, Brooke and Sarofim, Sarah and Chutipassakul, Chanidapa and Guthrie, Jeffrey and Heyl, Deborah and Evans, Hedeel Guy},
title = {Nicotine-Induced VEGF Levels in NSCLC Cells Are Modulated by PKA, Hyaluronan, and p53},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262211103}
}
EUVIMED